Literature DB >> 24063842

Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction.

Ashvarya Mangla1, John Kane, Elijah Beaty, DeJuran Richardson, Lynda H Powell, James E Calvin.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) is recognized as a major cause of cardiovascular morbidity and mortality. An ability to identify patients with HFpEF who are at increased risk for adverse outcomes can facilitate their more careful management. We studied the patients having heart failure (HF) using data from the Heart Failure Adherence and Retention Trial (HART). HART enrolled 902 patients in the New York Heart Association (NYHA) class II or III who had been recently hospitalized for HF to study the impact of self-management counseling on the primary outcome of death or HF hospitalization. In HART, 208 patients had HFpEF and 692 had HF with reduced ejection fraction (HFrEF) and were followed for a median of 1,080 days. Two final multivariate models were developed. In patients having HFpEF, predictors of primary outcome were male gender (odds ratio [OR] 3.45, p = 0.004), NYHA class III (OR 3.05, p = 0.008), distance covered on a 6-minute walk test (6-MWT) of <620 feet (OR 2.81, p = 0.013), and <80% adherence to prescribed medications (OR 2.61, p = 0.018). In patients having HFrEF, the predictors were being on diuretics (OR 3.06, p = 0.001), having ≥3 co-morbidities (OR 2.11, p = 0.0001), distance covered on a 6-MWT of <620 feet (OR 1.94, p = 0.001), NYHA class III (OR 1.90, p = 0.001), and age >65 years (OR 1.63, p = 0.01). In conclusion, indicators of functional status (6-MWT and NYHA class) were common to both patients with HFpEF and those with HFrEF, whereas gender and adherence to prescribed therapy were unique to patients having HFpEF in predicting death or HF hospitalization.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24063842      PMCID: PMC3880823          DOI: 10.1016/j.amjcard.2013.08.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

2.  Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial.

Authors:  Lynda H Powell; James E Calvin; Dejuran Richardson; Imke Janssen; Carlos F Mendes de Leon; Kristin J Flynn; Kathleen L Grady; Cheryl S Rucker-Whitaker; Claudia Eaton; Elizabeth Avery
Journal:  JAMA       Date:  2010-09-22       Impact factor: 56.272

3.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

4.  One-year mortality among unselected outpatients with heart failure.

Authors:  J Muntwyler; G Abetel; C Gruner; F Follath
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

5.  Predicting mortality in patients with heart failure: a pragmatic approach.

Authors:  M L Bouvy; E R Heerdink; H G M Leufkens; A W Hoes
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

6.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

7.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators.

Authors:  V Bittner; D H Weiner; S Yusuf; W J Rogers; K M McIntyre; S I Bangdiwala; M W Kronenberg; J B Kostis; R M Kohn; M Guillotte
Journal:  JAMA       Date:  1993-10-13       Impact factor: 56.272

8.  Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms.

Authors:  B K Madsen; J F Hansen; K H Stokholm; J Brøns; D Husum; L S Mortensen
Journal:  Eur Heart J       Date:  1994-03       Impact factor: 29.983

9.  Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring.

Authors:  D Scrutinio; R Lagioia; A Ricci; M Clemente; L Boni; P Rizzon
Journal:  Eur Heart J       Date:  1994-08       Impact factor: 29.983

10.  Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation.

Authors:  Carlo Rostagno; Giuseppe Olivo; Marco Comeglio; Vieri Boddi; Michela Banchelli; Giorgio Galanti; Gian Franco Gensini
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

View more
  9 in total

Review 1.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  The Associations of Diagnoses of Fatigue and Depression With Use of Medical Services in Patients With Heart Failure.

Authors:  Seongkum Heo; Jean McSweeney; Pao-Feng Tsai; Songthip Ounpraseuth; Debra K Moser; JinShil Kim
Journal:  J Cardiovasc Nurs       Date:  2019 Jul/Aug       Impact factor: 2.083

3.  Using Physical Function to Predict Hospital Readmission within 1 Year in Patients with Heart Failure.

Authors:  Hiroaki Teramatsu; Junichiro Shiraishi; Yasuyuki Matsushima; Masaru Araki; Tetsuya Okazaki; Satoru Saeki
Journal:  Prog Rehabil Med       Date:  2019-10-19

4.  Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction.

Authors:  Daisaku Nakatani; Tomoharu Dohi; Toshihiro Takeda; Katsuki Okada; Akihiro Sunaga; Bolrathanak Oeun; Hirota Kida; Yohei Sotomi; Taiki Sato; Tetsuhisa Kitamura; Shinichiro Suna; Hiroya Mizuno; Shungo Hikoso; Yasushi Matsumura; Yasushi Sakata
Journal:  Circ Rep       Date:  2022-04-23

5.  The Association Between Life-Space and Health Care Utilization in Older Adults with Heart Failure.

Authors:  Alexander X Lo; Kellie L Flood; Richard E Kennedy; Vera Bittner; Patricia Sawyer; Richard M Allman; Cynthia J Brown
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-07-28       Impact factor: 6.053

6.  The effect of emphysema on readmission and survival among smokers with heart failure.

Authors:  Puja Kohli; Pedro V Staziaki; Sumbal A Janjua; Daniel A Addison; Travis R Hallett; Orla Hennessy; Richard A P Takx; Michael T Lu; Florian J Fintelmann; Marc Semigran; Robert S Harris; Bartolome R Celli; Udo Hoffmann; Tomas G Neilan
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

7.  Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.

Authors:  Prathap Kanagala; Jayanth R Arnold; Anvesha Singh; Daniel C S Chan; Adrian S H Cheng; Jamal N Khan; Gaurav S Gulsin; Jing Yang; Lei Zhao; Pankaj Gupta; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

8.  Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis.

Authors:  Iván José Fuentes-Abolafio; Brendon Stubbs; Luis Miguel Pérez-Belmonte; María Rosa Bernal-López; Ricardo Gómez-Huelgas; Antonio Ignacio Cuesta-Vargas
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

9.  Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization.

Authors:  Satoshi Suzuki; Akiomi Yoshihisa; Yu Sato; Yuki Kanno; Shunsuke Watanabe; Satoshi Abe; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.